LXRX

Lexicon Pharmaceuticals, Inc. (LXRX) is a biopharmaceutical company headquartered in The Woodlands, Texas, dedicated to the discovery, development, and commercialization of innovative therapies for metabolic and neuroendocrine disorders. Leveraging its proprietary gene-targeting technologies, Lexicon is advancing a diverse pipeline of novel therapies designed to meet substantial unmet medical needs in these critical therapeutic areas. With a robust leadership team committed to scientific excellence, the company is well-positioned to enhance patient outcomes while pursuing sustainable growth in the dynamic healthcare sector.